Evidence map›Paper›PMID 38396295›Full record

ArticleOncogene2024

Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.

L Damiano, K M Stewart, N Cohet, J K Mouw, J N Lakins, J Debnath, D Reisman, J A Nickerson, A N Imbalzano, V M Weaver

RetractedOpen access · bronzeAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

L Damiano *Department of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA.
K M Stewart *Department of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA.
N CohetDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, USA.
J K MouwDepartment of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA.
J N LakinsDepartment of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA.
J DebnathDepartment of Pathology, University of California-San Francisco, San Francisco, CA, USA.
D ReismanDivision of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
J A NickersonDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, USA.
A N ImbalzanoDepartment of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, MA, USA.
V M WeaverDepartment of Surgery, Center for Bioengineering and Tissue Regeneration, University of California-San Francisco, San Francisco, CA, USA. Valerie.Weaver@ucsfmedctr.org.
University of California, San Francisco · USUniversity of Massachusetts Chan Medical School · USUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38396295
PMCPMC11036532
OpenAlexW4392099414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.